Lyme disease vaccine market to reach $1.57 billion by 2030 at 7.0% CAGR, driven by increasing prevalence of lyme disease and rising healthcare expenditure.
Read More
Lung cancer drugs market to reach $88.06 billion by 2030 at 10.9% CAGR, driven by rising prevalence rate of lung cancer.
Read More
Monoclonal antibodies market to reach $464.39 billion by 2030 at 12.6% CAGR, driven by increasing prevalence of cost-efficient biosimilar monoclonal antibodies.
Read More
Lumbosacral radicular pain management market to reach $1.17 billion by 2030 at 5.4% CAGR, driven by rising prevalence of back pain disorders.
Read More
Molecular targeted therapy market to reach $107.64 billion by 2030 at 8.4% CAGR, driven by rise of personalized medicine.
Read More
Lumbosacral radicular pain market to reach $1.28 billion by 2030 at 5.7% CAGR, driven by increasing prevalence of degenerative spinal conditions and rising prevalence of obesity.
Read More
Modular fill-finish micro-factory market to reach $2.96 billion by 2030 at 11.1% CAGR, driven by increasing demand for personalized medicines.
Read More
Losartan potassium active pharmaceutical ingredient (api) market to reach $2.54 billion by 2030 at 6.5% CAGR, driven by growing prevalence of hypertension.
Read More
Minimal residual disease testing market to reach $3.31 billion by 2030 at 13.1% CAGR, driven by increasing prevalence of cancer.
Read More
Local anesthesia drugs market to reach $6.15 billion by 2030 at 5.6% CAGR, driven by increase in prevalence of chronic diseases.
Read More